Pharmasim Swot Analysis
PharmaSim SWOT analysis and 10 year goals for AllStar Brand Management Team
MBA 6210 Marketing Management
Introduction:
Allstar’s Pharmaceutical division has a multi-symptom cold OTC medication (Allround) that is competing against nine brands from four competitors. The intent of this exercise is to evaluate Allround’s current position in the market, by analyzing its strengths, weaknesses, opportunities, and threats. There is also a proposed 10 year goal plan and strategy to establish Allstar as the industry leader of the OTC cold remedy market, while maintaining long term sustaining profitability.
SWOT Analysis:
Company
Allstar is one of the leading companies in the OTC cold and allergy remedy market with the second highest sales in the industry the previous year. Its Allround product is the market leader in cold and allergy relief segments. Allround is a significant contributor towards AllStar’s sales and is viewed as one of the major factors that determine AllStar’s financial performance. AllStar primarily rides on Allround’s strengths that include highest market share in its product segment, very high brand awareness, and a high conversion ratio. Allstar also has an organized management team as well as an organized and productive R&D department, enabling it to be an innovative leader in the industry across its portfolio. From the financial reports of the competitors, it can be observed that Allround has a lower % of fixed costs to sales, compared to competitors. However the impact of Allround on Allstar is so high that the company relies on the cash flows that Allround generates to allow the company to pursue new opportunities, and unfortunately there was a dip in the performance of Allround leading to poor Allstar performance the previous quarter. This is a potential weakness as it makes the company solely rely on one product in its portfolio and rides or sinks with it. Allstar should focus on getting into other products and have a healthy
MBA 6210 Marketing Management
Introduction:
Allstar’s Pharmaceutical division has a multi-symptom cold OTC medication (Allround) that is competing against nine brands from four competitors. The intent of this exercise is to evaluate Allround’s current position in the market, by analyzing its strengths, weaknesses, opportunities, and threats. There is also a proposed 10 year goal plan and strategy to establish Allstar as the industry leader of the OTC cold remedy market, while maintaining long term sustaining profitability.
SWOT Analysis:
Company
Allstar is one of the leading companies in the OTC cold and allergy remedy market with the second highest sales in the industry the previous year. Its Allround product is the market leader in cold and allergy relief segments. Allround is a significant contributor towards AllStar’s sales and is viewed as one of the major factors that determine AllStar’s financial performance. AllStar primarily rides on Allround’s strengths that include highest market share in its product segment, very high brand awareness, and a high conversion ratio. Allstar also has an organized management team as well as an organized and productive R&D department, enabling it to be an innovative leader in the industry across its portfolio. From the financial reports of the competitors, it can be observed that Allround has a lower % of fixed costs to sales, compared to competitors. However the impact of Allround on Allstar is so high that the company relies on the cash flows that Allround generates to allow the company to pursue new opportunities, and unfortunately there was a dip in the performance of Allround leading to poor Allstar performance the previous quarter. This is a potential weakness as it makes the company solely rely on one product in its portfolio and rides or sinks with it. Allstar should focus on getting into other products and have a healthy